ANTIBODY PREVALENCE TO HEPATITIS-C AND PARENTERAL TRANSMITTED VIRUS DISEASES IN INTRAVENOUS-DRUG-USERS

被引:0
|
作者
NEUWALD, C [1 ]
PONT, J [1 ]
TOMASITS, J [1 ]
BAUER, K [1 ]
机构
[1] STADT WIEN,KAISER FRANZ JOSEF SPITALS,MED ABT 3,A-1100 VIENNA,AUSTRIA
关键词
IV DRUG USERS; HEPATITIS-C; HEPATITIS-B; HIV; HTLV-I;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serum samples of 151 intravenous drug users were tested for markers of hepatitis B, hepatitis C, HIV and HTLV-I infection to estimate the prevalence of blood born virus infection in this high risk group. Anti-HCV antibodies were found in 75% of sera. Seroprevalence for HIV was found 13%, for hepatitis B markers 68% and none for HTLV-I. Multiple infections have been very frequent.
引用
收藏
页码:47 / 48
页数:2
相关论文
共 50 条
  • [21] ASSESSMENT AND MEDICAL FOLLOW-UP OF INTRAVENOUS-DRUG-USERS (IVDU) POSITIVE FOR HEPATITIS-C VIRUS (HCV) IN NORTH-EAST ENGLAND
    BRIND, AM
    SERFATY, MA
    LAWRIE, A
    WATSON, JP
    JOHNSON, S
    GILVARRY, E
    BASSENDINE, MF
    HEPATOLOGY, 1995, 22 (04) : 1114 - 1114
  • [22] THE PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN A DIALYSIS POPULATION
    HAY, NM
    LYNN, KL
    SCHOUSBOE, MI
    NEW ZEALAND MEDICAL JOURNAL, 1992, 105 (931) : 134 - 134
  • [23] HEPATITIS-C IN HIV-INFECTED INTRAVENOUS-DRUG-USERS AND HOMOSEXUAL MEN IN SUBURBAN NEW-YORK-CITY
    WORMSER, GP
    FORSETER, G
    JOLINE, C
    TUPPER, B
    OBRIEN, TA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (22): : 2958 - 2958
  • [24] PARENTERAL AND SEXUAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN INTRAVENOUS-DRUG-USERS - A STUDY OF SEROCONVERSION
    NICOLOSI, A
    LEITE, MLC
    MUSICCO, M
    MOLINARI, S
    LAZZARIN, A
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (03) : 225 - 233
  • [25] IgM antibody response to the hepatitis C virus core protein in intravenous drug users
    Toniutto, P
    Falleti, E
    Gasparini, V
    Fabris, C
    Tisminetzky, SG
    Lombardelli, T
    Pacco, P
    Satta, A
    Pirisi, M
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (02) : 69 - 73
  • [26] Hepatitis C virus infection in intravenous drug users
    Harder, J
    Walter, E
    Riecken, B
    Ihling, C
    Bauer, TM
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (08) : 768 - 770
  • [27] ANTIBODY PREVALENCE OF PARENTERALLY TRANSMITTED VIRUSES (HIV-1, HTLV-I, HBV, HCV) IN AUSTRIAN INTRAVENOUS-DRUG-USERS
    PONT, J
    NEUWALD, C
    SALZNER, G
    INFECTION, 1991, 19 (06) : 427 - 430
  • [28] High hepatitis C virus prevalence and incidence among Canadian intravenous drug users
    Roy, E.
    Alary, M.
    Morissette, C.
    Leclerc, P.
    Boudreau, J. -F.
    Parent, R.
    Rochefort, J.
    Claessens, C.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2007, 18 (01) : 23 - 27
  • [29] SEROPREVALENCE OF THE HEPATITIS-C VIRUS IN INTRAVENOUS DRUG-ABUSERS
    SANCHEZ, AMM
    SANCHEZ, MC
    NAVARES, AA
    DESANLORENZO, AS
    MEDICINA CLINICA, 1992, 99 (17): : 675 - 676
  • [30] PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN HEMODIALYSIS-PATIENTS
    HAYASHI, J
    NAKASHIMA, K
    KAJIYAMA, W
    NOGUCHI, A
    MOROFUJI, M
    MAEDA, Y
    KASHIWAGI, S
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 134 (06) : 651 - 657